NCT07109336
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,067 public trials
1,185 recruiting studies
Adenocarcinoma trial results
Not yet recruiting
Predictors of HCC in Post-HCV Cirrhotic Patients After SVR
NCT07097870
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Faculty of Medicine, Sohag Univesity Sohag, Egypt
Not yet recruiting
29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness
NCT07100236
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
- Cancer Hospital, Chinese Academy of Medical Sciences Chaoyang, Beijing Municipality, China
- Fujian Provincial Hospital Fuzhou, Fujian, China
- The First Affiliated Hospital of Sun Yat - sen University Guangzhou, Guangdong, China
Not yet recruiting
Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B Virus
NCT07088133
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
Not specified
Not yet recruiting
Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection
NCT07077798
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
Not specified
Not yet recruiting
WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy
NCT07077369
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Not yet recruiting
The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study
NCT07078292
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
Not specified
Not yet recruiting
Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment
NCT07078305
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Not yet recruiting
JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure
NCT07075419
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
Not yet recruiting
Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study
NCT07064668
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Tongji Medical college of HUST Wuhan, Hubei, China